These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24627446)

  • 1. Uptake and metabolic effects of 3-iodothyronamine in hepatocytes.
    Ghelardoni S; Chiellini G; Frascarelli S; Saba A; Zucchi R
    J Endocrinol; 2014 Apr; 221(1):101-10. PubMed ID: 24627446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution and cardiac metabolism of 3-iodothyronamine.
    Saba A; Chiellini G; Frascarelli S; Marchini M; Ghelardoni S; Raffaelli A; Tonacchera M; Vitti P; Scanlan TS; Zucchi R
    Endocrinology; 2010 Oct; 151(10):5063-73. PubMed ID: 20739399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine.
    Laurino A; De Siena G; Saba A; Chiellini G; Landucci E; Zucchi R; Raimondi L
    Eur J Pharmacol; 2015 Aug; 761():130-4. PubMed ID: 25941083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Iodothyronamine and 3,5,3'-triiodo-L-thyronine reduce SIRT1 protein expression in the HepG2 cell line.
    Sacripanti G; Lorenzini L; Bandini L; Frascarelli S; Zucchi R; Ghelardoni S
    Horm Mol Biol Clin Investig; 2020 Mar; 41(1):. PubMed ID: 32114521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 3-iodothyronamine in vitro dynamics by mathematical modeling.
    Orsi G; Ghelardoni S; Saba A; Zucchi R; Vozzi G
    Cell Biochem Biophys; 2014 Jan; 68(1):37-47. PubMed ID: 23723010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1).
    Gencarelli M; Lodovici M; Bellusci L; Raimondi L; Laurino A
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyronamines and Derivatives: Physiological Relevance, Pharmacological Actions, and Future Research Directions.
    Hoefig CS; Zucchi R; Köhrle J
    Thyroid; 2016 Dec; 26(12):1656-1673. PubMed ID: 27650974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyronamines are substrates for human liver sulfotransferases.
    Pietsch CA; Scanlan TS; Anderson RJ
    Endocrinology; 2007 Apr; 148(4):1921-7. PubMed ID: 17204552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel thyroid hormones.
    Zucchi R; Rutigliano G; Saponaro F
    Endocrine; 2019 Oct; 66(1):95-104. PubMed ID: 31327156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of 3-Iodothyronamine and Derivatives in Biological Matrixes: Problems and Pitfalls.
    Lorenzini L; Ghelardoni S; Saba A; Sacripanti G; Chiellini G; Zucchi R
    Thyroid; 2017 Oct; 27(10):1323-1331. PubMed ID: 28859548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Iodothyronamine Decreases Expression of Genes Involved in Iodide Metabolism in Mouse Thyroids and Inhibits Iodide Uptake in PCCL3 Thyrocytes.
    Schanze N; Jacobi SF; Rijntjes E; Mergler S; Del Olmo M; Hoefig CS; Khajavi N; Lehmphul I; Biebermann H; Mittag J; Köhrle J
    Thyroid; 2017 Jan; 27(1):11-22. PubMed ID: 27788620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on 3-iodothyronamine and its neurological and metabolic actions.
    Zucchi R; Accorroni A; Chiellini G
    Front Physiol; 2014; 5():402. PubMed ID: 25360120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac actions of thyroid hormone metabolites.
    Rutigliano G; Zucchi R
    Mol Cell Endocrinol; 2017 Dec; 458():76-81. PubMed ID: 28069537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Iodothyronamine reduces insulin secretion in vitro via a mitochondrial mechanism.
    Lehmphul I; Hoefig CS; Köhrle J
    Mol Cell Endocrinol; 2018 Jan; 460():219-228. PubMed ID: 28754352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine, Metabolic and Pharmacological Effects of Thyronamines (TAM), Thyroacetic Acids (TA) and Thyroid Hormone Metabolites (THM) - Evidence from in vitro, Cellular, Experimental Animal and Human Studies.
    Homuth G; Lietzow J; Schanze N; Golchert J; Köhrle J
    Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):401-413. PubMed ID: 32450582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of gene expression by 3-iodothyronamine: genetic evidence for a lipolytic pattern.
    Mariotti V; Melissari E; Iofrida C; Righi M; Di Russo M; Donzelli R; Saba A; Frascarelli S; Chiellini G; Zucchi R; Pellegrini S
    PLoS One; 2014; 9(11):e106923. PubMed ID: 25379707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 3-iodothyronamine (T1AM) and the 3-iodothyroacetic acid (TA1) indicate a novel connection with the histamine system for neuroprotection.
    Laurino A; Gencarelli M; Raimondi L
    Eur J Pharmacol; 2021 Dec; 912():174606. PubMed ID: 34717926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway.
    Rogowski M; Bellusci L; Sabatini M; Rapposelli S; Rahman SM; Chiellini G; Assadi-Porter FM
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of Thyronamines (TAMs) to the Brain: A Preliminary Study.
    di Leo N; Moscato S; Borso' M; Sestito S; Polini B; Bandini L; Grillone A; Battaglini M; Saba A; Mattii L; Ciofani G; Chiellini G
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fatty acids, glucose, and insulin on hepatic glucose uptake and glycolysis.
    Swagell CD; Morris CP; Henly DC
    Nutrition; 2006 Jun; 22(6):672-8. PubMed ID: 16704955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.